These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332 [TBL] [Abstract][Full Text] [Related]
4. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis]. Voznesenskaia TS; Sergeeva TV Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479 [TBL] [Abstract][Full Text] [Related]
5. CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis? Davin JC Pediatr Nephrol; 2014 Aug; 29(8):1465-6. PubMed ID: 24839215 [No Abstract] [Full Text] [Related]
6. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Cara-Fuentes G; Johnson RJ; Reiser J; Garin EH Pediatr Nephrol; 2014 Aug; 29(8):1467-8. PubMed ID: 24817342 [No Abstract] [Full Text] [Related]
7. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse. Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663 [TBL] [Abstract][Full Text] [Related]
8. A 52-year-old female with nephrotic syndrome and ischaemic heart disease. Natl Med J India; 1994; 7(3):136-9. PubMed ID: 8069207 [No Abstract] [Full Text] [Related]
15. The application of electron microscopic morphometry as a helpful method in the diagnosis of focal segmental glomerulosclerosis (FSGS) early phase. II. Clinical usefulness of electron microscopic morphometric studies in cases of minimal change disease (MCD) and mesangioproliferative glomerulonephritis (GNMES) with suspicion of progression into focal segmental glomerulosclerosis (FSGS). Woźniak A; Bortkiewicz E; Salwa-Zurawska W; Kaczmarek E; Maciejewski J Pol J Pathol; 2001; 52(1-2):37-46. PubMed ID: 11505679 [TBL] [Abstract][Full Text] [Related]
20. [A solid phase direct radioimmunoassay for urinary thromboxane B2 and its clinical application]. Uehara Y; Doi M; Kobayashi T; Takagi M; Ishii M; Sugimoto T Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1301-8. PubMed ID: 6527429 [No Abstract] [Full Text] [Related] [Next] [New Search]